Literature DB >> 11315889

Detection of gastric cancer by repeat endoscopy within a short time after negative examination.

O Hosokawa1, K Watanabe, M Hatorri, K Douden, H Hayashi, Y Kaizaki.   

Abstract

BACKGROUND AND STUDY AIMS: Although a large number of patients are examined using endoscopy in order to identify gastric cancer, it is unclear how individuals should be managed after they are not diagnosed as having gastric cancer at the time of their initial examinations. This study was conducted to identify the group at high risk for gastric cancer who should be examined by repeat endoscopy within a short time after obtaining negative results. PATIENTS AND METHODS: The study involved 3672 patients who were not diagnosed as having gastric cancer by endoscopy in 1993, but underwent re-examination by gastroscopy between January 1994 and December 1996.
RESULTS: Among these participants, 32 patients (0.9%) were diagnosed as having gastric cancer. The incidence of gastric cancer was 2.0% in participants aged 60 to 69 and 2.7% in those with marked atrophy of the gastric mucosa. Multivariate analysis showed that the odds ratios (OR) for patients aged 60 to 69 and those with marked atrophy of the gastric mucosa were 3.092 and 3.255 (P < 0.01), respectively. Gastric cancer was detected in 17.2 % of patients who were previously diagnosed as having gastric adenoma and in 2.2% of those who were previously diagnosed as having gastric ulcer. The ORs for participants with these gastric lesions detected by the initial examination were 49.417 and 5.259 (P < 0.01), respectively.
CONCLUSIONS: Groups at high risk for gastric cancer were identified by the initial endoscopy, when two findings (gastric lesions, atrophy) and age were combined. We emphasize the importance of repeat endoscopic examination for patients who are aged 60 to 69 or have marked atrophy of gastric mucosa, even if no lesions are detected on initial endoscopy. If gastric adenoma or ulcer are detected, endoscopic examination should be likewise repeated or these lesions should be treated by endoscopy or by other means.

Entities:  

Mesh:

Year:  2001        PMID: 11315889     DOI: 10.1055/s-2001-13685

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  14 in total

1.  Missed cancers in the upper gastrointestinal tract after esophagogastroduodenoscopy.

Authors:  Robert Enns
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-11

2.  Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival.

Authors:  Jennifer M Yeh; Wendy Ho; Chin Hur
Journal:  Gastrointest Endosc       Date:  2010-04-28       Impact factor: 9.427

3.  How well is Helicobacter pylori treated in usual practice?

Authors:  Kumaresan Yogeswaran; Grant Chen; Lawrence Cohen; Mary Anne Cooper; Elaine Yong; Eugene Hsieh; Corwyn Rowsell; Fred Saibil; Jill Tinmouth
Journal:  Can J Gastroenterol       Date:  2011-10       Impact factor: 3.522

4.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

5.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

6.  Detection of early gastric cancer: misunderstanding the role of mass screening.

Authors:  Haruhisa Suzuki; Takuji Gotoda; Mitsuru Sasako; Daizo Saito
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

7.  Missed diagnosis of early gastric cancer or high-grade intraepithelial neoplasia.

Authors:  Wei Ren; Jin Yu; Zhi-Mei Zhang; Yuan-Kun Song; Yi-Hui Li; Lei Wang
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

8.  Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy.

Authors:  Mohammad H Shakhatreh; Zhigang Duan; Nathaniel Avila; Aanand D Naik; Jennifer R Kramer; Marilyn Hinojosa-Lindsey; John Chen; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-05       Impact factor: 11.382

Review 9.  Medical versus surgical treatment for refractory or recurrent peptic ulcer.

Authors:  Kurinchi Selvan Gurusamy; Elena Pallari
Journal:  Cochrane Database Syst Rev       Date:  2016-03-29

Review 10.  The risk of gastric cancer in patients with duodenal and gastric ulcer: research progresses and clinical implications.

Authors:  Zunwu Zhang
Journal:  J Gastrointest Cancer       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.